You have 9 free searches left this month | for more free features.

City

Shanghai (2)

Tianjin (1)

Condition

Non-Small Cell Lung Cancer (2)

Medullary Thyroid Cancer (1)

Solid Tumor (1)

Overall Status

Recruiting (2)

Sign in for free

Phase

phase 1 (1)

phase 3 (1)

Sponsor

Shouyao Holdings (Beijing) Co. LTD (2)

Collaborator

Intervention

sy-5007 (2)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

sy-5007

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

NSCLC Trial in Shanghai (SY-5007)

Recruiting

Non-Small Cell Lung Cancer

SY-5007

Shanghai, Shanghai, China

Shanghai Pulmonary Hospital

Sep 4, 2023

NSCLC, Medullary Thyroid Cancer, Solid Tumor Trial in Shanghai, Tianjin (SY-5007)

Recruiting

Non-Small Cell Lung Cancer
+2 more

SY-5007

Shanghai, Shanghai, China
+1 more

Mar 17, 2022